TD Asset Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
FLAM
TCM
TD Asset Management's ANAB Position: Q2 2025 in Review
TD Asset Management sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 14,000 shares — an estimated $260K sold.
TD Asset Management first reported a position in ANAB in Q4 2017 and held it in 15 quarters. The position peaked at $1.98M in Q3 2024. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.
- TD Asset Management reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
- TD Asset Management sold 14,000 AnaptysBio shares in Q2 2025, an estimated $260K.
- TD Asset Management first reported a position in AnaptysBio in Q4 2017 and held it in 15 quarters.
- TD Asset Management's AnaptysBio position peaked at $1.98M in Q3 2024.
- 147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.
Based on TD Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.